These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2885931)

  • 21. [A long-term study of the visual fields in patients treated with betaxolol and timolol].
    Flammer J; Collignon-Brach J; Demailly P; Graves SA
    Oftalmologia; 1998; 42(1):77-82; discussion 82-3. PubMed ID: 9713206
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta adrenergic blocking agents for open-angle glaucoma.
    Lee ME
    J Am Optom Assoc; 1988 Jul; 59(7):567-71. PubMed ID: 2900260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The beta-adrenergic blocking agents and the treatment of glaucoma.
    Zimmerman TJ; Boger WP
    Surv Ophthalmol; 1979; 23(6):347-62. PubMed ID: 37605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of aqueous and gellan ophthalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for glaucoma.
    Dickstein K; Hapnes R; Aarsland T
    Am J Ophthalmol; 2001 Nov; 132(5):626-32. PubMed ID: 11704023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical effectiveness and mechanism of action of thymoptic in glaucoma].
    Shmyreva VF; Fridman NV; Makashova NV
    Vestn Oftalmol; 1982; (3):8-10. PubMed ID: 6126027
    [No Abstract]   [Full Text] [Related]  

  • 26. Beta-blocker eyedrops and nocturnal arterial hypotension.
    Hayreh SS; Podhajsky P; Zimmerman MB
    Am J Ophthalmol; 1999 Sep; 128(3):301-9. PubMed ID: 10511024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The comparative multiple-dose intraocular pressure responses of nadolol and timolol in glaucoma and ocular hypertension.
    Krieglstein GK; Mohamed J
    Acta Ophthalmol (Copenh); 1982 Apr; 60(2):284-92. PubMed ID: 6127861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Combination Glaucoma Therapies on β-Blocker Exposure.
    Xu K; Campbell EL; Gill SS; Nesdole R; Campbell RJ
    J Glaucoma; 2017 Feb; 26(2):e107-e109. PubMed ID: 28059862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S; Mundorf TK; Stewart JA; Stewart WC
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of betaxolol and timolol in open angle glaucoma and ocular hypertension.
    Feghali JG; Kaufman PL; Radius RL; Mandell AI
    Acta Ophthalmol (Copenh); 1988 Apr; 66(2):180-6. PubMed ID: 2898859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension.
    Frishman WH; Fuksbrumer MS; Tannenbaum M
    J Clin Pharmacol; 1994 Aug; 34(8):795-803. PubMed ID: 7962666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tolerance and tachyphylaxis during the long-term local treatment of different forms of glaucoma with Arutimol].
    Tost M; Herde J; Fincke S; Nook O
    Oftalmol Zh; 1989; (8):506-7. PubMed ID: 2576875
    [No Abstract]   [Full Text] [Related]  

  • 33. Systemic beta-blocker therapy and brimonidine and timolol.
    Coulibaly R
    Ophthalmology; 2001 Aug; 108(8):1368. PubMed ID: 11470677
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Michaud JE; Friren B;
    Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The beta-blockers in ophthalmology].
    Demailly P
    Rev Prat; 1984 Apr; 34(19):981-2. PubMed ID: 6144166
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.
    García Sanchez J
    Eur J Ophthalmol; 2000; 10(3):198-204. PubMed ID: 11071026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term intraocular pressure-lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with Timoptic XE 0.5% in a 12-month study.
    Schenker HI; Silver LH
    Am J Ophthalmol; 2000 Aug; 130(2):145-50. PubMed ID: 11004287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timolol: a review of its therapeutic efficacy in the topical treatment of glaucoma.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1979 Jan; 17(1):38-55. PubMed ID: 369807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of glaucoma with beta receptor blockers].
    Demmler N
    Fortschr Med; 1980 Jun; 98(23):880-5. PubMed ID: 6106627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brimonidine (Alphagan): a clinical profile four years after launch.
    David R
    Eur J Ophthalmol; 2001; 11 Suppl 2():S72-7. PubMed ID: 11592536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.